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The uptake and more importantly the subcellular distribution of photosensitizers are major determinants of their efficacy. In this paper, the
cellular internalization of chlorin e6 (Ce6), a photosensitizer bearing three carboxylic chains, is considered with emphasize on pH effects. Small
unilamellar vesicles are used as models to investigate the dynamics of interactions of Ce6 with membranes. The entrance and exit steps from the
outer lipid hemileaflet are very fast (∼ms). A slow transfer of Ce6 through the membrane was observed only for thin bilayers made of
dimyristoleoyl-phosphatidylcholine. Ce6 did not permeate through bilayers consisting of longer phospholipids more representative of biological
membranes. These results along with previous data on the interactions of Ce6 with low-density lipoproteins (LDL) are correlated with cellular
studies. After 15 min incubation of HS68 human fibroblasts with Ce6, fluorescence microscopy revealed labeling of the plasma membrane and
cytosolic vesicles different from lysosomes. When vectorized by LDL, Ce6 was mainly localized in lysosomes but absent from the plasma
membrane. Internalization of LDL bound photosensitizer via ApoB/E receptor mediated pathway was demonstrated by overexpression
experiments. A pH decrease from 7.4 to 6.9 did not affect the intracellular distribution of Ce6, but significantly increased its overall cellular
uptake.
© 2007 Elsevier B.V. All rights reserved.Keywords: Photosensitizer; Cellular uptake; Subcellular localization; pH; Lipoprotein; Model membranes1. Introduction
Photodynamic therapy (PDT), a promising treatment of
several oncologic and ophthalmologic diseases, is based on
light induced excitation of photosensitizing molecules, produc-
ing transient toxic species such as singlet oxygen and free
radicals [1,2]. Since the lifetime of these species is extremely
short, they diffuse poorly in a biological environment and the
photoinduced damages affect primarily the cell structures
labeled with the drug. Hence, the subcellular localization of
the photosensitizers is a major factor governing the extension of
the photoinduced cell damage as well as the mechanism of the
consequent cell death [3,4].⁎ Corresponding author. Laboratoire de Biophysique Moléculaire Cellulaire et
Tissulaire (BIOMOCETI) CNRS UMR 7033, Genopole Campus 1, 5 rue Henri
Desbruères, 91030 EVRY cedex, France. Fax: +33 1 69 87 43 60.
E-mail address: dbrault@ccr.jussieu.fr (D. Brault).
0005-2736/$ - see front matter © 2007 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbamem.2007.07.002Because of their enhanced absorption of light in the
“therapeutic” window (600–800 nm), chlorins are attractive
photosensitizing agents for therapeutic applications. In this series,
chlorin e6 (Ce6) and its derivatives display promising properties
[5,6]. Chlorin e6 is an asymmetric molecule bearing three
ionizable carboxylic groups. The neutralization of the charge of
these groups at slightly acidic pH increases the Ce6 lipophilicity.
As a consequence, its interactions with biological structures such
as plasma proteins and lipid membranes are modified. In a
previous study, we have shown that the Ce6 fraction bound to
lipid membranes and low density lipoproteins (LDL) increases
whereas the one bound to HSA decreases when the pH changes
from 7.4 to 6.5 [7]. Since the pH of tumor stroma is decreased
compared to that of normal tissue [8,9], the enhanced lipophilicity
might favor the cellular uptake of Ce6 by neoplastic cells and thus
increase the selectivity of the photosensitizer for tumors.
The cellular internalization pathway and subcellular localization
are related to the structural and physico-chemical characteristics of
Fig. 1. Structure of Chlorin e6 (Ce6).
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passive diffusion through the plasma membrane, or by following
the endocytosis pathway. The balance between these two
mechanisms is determined by the interactions of the photosensi-
tizer with cell membranes and blood carriers, especially with LDL.
As a matter of fact, LDL have been proposed by several authors to
be carriers of hydrophobic photosensitizers [10–13].Moreover, the
increased cholesterol need of proliferating tissues induces the over-
expression of apo B/E receptors on the cell surface [14,15]. Thus,
the cellular incorporation of lipoprotein bound sensitizers via LDL
specific endocytosis may be one of the mechanisms leading to the
preferential retention of the photosensitizers by tumors.
The aimof the presentwork is to evaluate the effect of decreased
pH on the cellular internalization and the mechanism of cellular
entrance of Ce6. Firstly, models of lipid membranes are used to
study the effect of pH on the kinetics of the interactions between
Ce6 and the lipid bilayer. In the second part, these physico-
chemical parameters are correlated with the cellular internalization
and the subcellular localization of free and LDL-bound Ce6.
2. Materials and methods
2.1. Chemicals
Chlorin e6 (Fig. 1) was purchased from Porphyrin Products, Logan (UT,
USA). A stock solution (1 mM) was prepared in 20 mM Na2HPO4. The
experimental Ce6 solutions were diluted in PBS (20 mM Na2HPO4, 20 mM
KH2PO4, 150 mM NaCl, pH=7.4) and handled in the dark to avoid any
photobleaching.Fig. 2. Scheme of Ce6–liHuman low-density lipoproteins (LDL) were purchased from Calbiochem
(San Diego, CA, USA). They were conditioned at a concentration of 9.52 mg/ml
(protein content) in 150 mM NaCl, pH 7.4 aqueous solution with 0.01% EDTA.
Chloroform (MERCK, Darmstadt, Germany) was of spectroscopic grade quality.
2.2. Liposome preparation
Dioleoyl-sn-phosphatidylcholine (DOPC, C18:1) and Dimyristoleoyl-sn-
phosphatidylcholine (DMoPC, C14:1) were purchased from Avanti Polar Lipids
(Alabaster, AL, USA). Lipids were dissolved in chloroform and the solution was
taken to dryness. The lipid film obtained was rehydrated by PBS and vortexed
for several minutes. The liposome suspension was extruded 10 times through a
stack of two polycarbonate membrane filters (Poretics, Livermore, Ca, USA)
with a pore size of 100 nm, by using an extruder device (Lipex, Biomembranes,
Vancouver, Canada).
2.3. Kinetics measurements
Fast kinetics measurements were performed at either 20 °C or 37 °C by using
a stopped flow apparatus (Applied Photophysics, Leatherhead, UK) with a
mixing time of 1.2ms. The excitationwas provided by a 150-WXenon lamp. The
slits of the excitation monochromator were set to give a bandwidth of 4.65 nm.
The emitted light was collected thought a 665-nm cut-off filter (Oriel, Palaiseau,
France) that transmits red light. The wavelength of 665 nm corresponds to 50%
transmittance. As shown by preliminary experiments, the excitation wavelength
yielding the best signal was 411 nm. The signal was processed by a RISC
workstation (Acorn Computers, Cambridge, UK). The data analysis was
performed by using the Kaleidagraph® software (Synergie Software, PA, USA).
Slow kinetics measurements were performed with an Aminco Bowman
Series 2 spectrofluorimeter (Edison, NJ, USA). The excitation wavelength was
set to 408 nm and the time trace of the fluorescence emission at 670 nm was
recorded. The emission wavelength (670 nm) was slightly red-shifted compared
to the emission maximum of Ce6 (668 nm) in order to detect kinetics signal with
maximal amplitude. The same set of wavelength was used in our previous paper
[7] to analyze equilibrium data.
2.4. Cell culture experiments
Cells from the human fibroblast cell line HS68 were grown at 37 °C (5%
CO2 atmosphere) in DMEM (Dulbecco's Minimum Eagle Medium) supple-
mented with 10% foetal calf serum (FCS) and 100 U/mol Penicillin/
Streptomycin. The cellular experiments were performed at pH 7.4 and 6.9.
The acidic pH value is higher than 6.5 used in kinetics experiments because of
fragility of the cell culture. Spectroscopic studies have shown that the pH
decrease to 6.9 is sufficient to establish the Ce6 protonation equilibria shift
towards the neutralization of the carboxyl groups.
2.4.1. Quantification of Ce6 uptake
HS68 cells were seeded in Petri dishes and collected at confluence for the
experiments. The cells were washed with HBSS (Hank's balanced salt solution)
and incubated for 15minwithHBSS containing 5×10−7MCe6 alone or preloaded
in 1×10−7 M LDL. Taking into account the lipoprotein concentration and LDL
binding constant value KLDL=6.9×10
7 M [7], more than 85% of Ce6 molecules
were bound to LDL in these conditions. After incubation, the cells were washedposome interactions.
Fig. 3. Kinetics of the Ce6 interactions with the lipid vesicles at pH=7.4. (a): The
first phase of the Ce6 incorporation. The fluorescence intensity changes uponmixing
DOPC liposomes (1×10−4 M) with Ce6 (5×10−7 M), t=20 °C. (a) inset: Fast
phase rate constant k1 versus DOPC concentration. [Ce6]=5×10
−7 M. The slope
and the intercept at the origin of the linear fit give the values of kon
obs=6.88×105 M−1
s−1 and koff
obs=125 s−1. (b): The slow phase of the Ce6 interaction with the lipid
vesicles. The fluorescence intensity changes upon mixing DOPC and DMoPC
liposomes (1×10−4 M) with Ce6 (5×10−7 M) recorded by using the
spectrofluorimeter. The temperature was increased up to 37 °C. Excitation
wavelength was set at 410 nm, the fluorescence intensity was measured at
670 nm, where the differences between the fluorescence of Ce6 in aqueous and lipid
environment are the most pronounced. The experimental data were fitted by a
monoexponential equation giving the rate constant value k2=(2.0±0.3)×10
−3 s−1.
Fig. 4. Kinetics of the Ce6 interactions with the lipid vesicles at pH=6.5. (a): The
first phase of the Ce6 incorporation: the fluorescence intensity changes upon
mixing DOPC liposomes (1×10−4 M) with Ce6 (5×10−7 M), t=20 °C. (a)
Inset: Fast phase rate constant versus DOPC concentration, [Ce6]=5×10−7 M.
The slope and the intercept at the origin of the linear fit give the values of
kon
obs=5.6×105 M−1 s−1 and koff
obs=58 s−1. (b) Slow phase of the Ce6 interaction
with lipid vesicles at pH 6.5. The fluorescence intensity changes upon mixing
Ce6 (5×10−7 M) and DMoPC liposomes (1×10−4 M). Excitation wavelength
was set at 411 nm. The experimental data were fitted by a monoexponential
equation giving k2= (26.3±0.1)×10
−3 s−1, t=37 °C.
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3% Triton X-100 (100 μl) was added to the suspension in order to disrupt the
membranes. The fluorescence spectra were measured and compared to calibration
curves made with known photosensitizer concentrations in 0.3% Triton X-100
solution. The protein content was determined by the Lowry's method [16]. All
experiments were performed in triplicate and the mean values of Ce6 concentration
per gram of protein (±standard deviation) were calculated.
2.4.2. LDL bound Ce6 receptor mediated uptake
In order to enhance the expression of LDL receptors on the cell surface, the
HS68 fibroblasts were incubated during 48 h with DMEM medium
supplemented with 2% Ultroser G [17]. After incubation, the cellular uptake
of Ce6 free or associated to LDL was assessed. In parallel, experiments were
carried out with cells pre-incubated with DMEM supplemented with 10% FCS.
For each type of experiments (Ce6 free or associated to LDL), the mean value
for three independent measurements was determined and the uptake was
independently normalized to the “non over expressed” samples.
2.4.3. Microscopy experiments and subcellular localization
HS68 cells were seeded on a 0.17-mm thick cover glass 24 h before the
experiment. The cells were washed twice with HBSS and incubated for 30 minwith 200 nM LysoTracker® green. Then, the cells were incubated for 15 min
with HBSS containing 5×10−7 M Ce6, alone or preloaded in 1×10−7 M LDL.
Ce6 was excited through a bandpass filter 330–380 nm and the red
fluorescence emission of the samples was collected through a 645±75 nm,
Omega bandpass filter. For LysoTracker® excitation a bandpass filter (484 nm)
and a dichroic mirror at 400 nm were used. The LysoTracker® fluorescence
signal was collected through a bandpass filter (535±45 nm, Omega). The use of
different excitation and emission filters allowed a good separation of the Ce6 red
emission from the green emission of LysoTracker®. The autofluorescence of
controls containing LDL alone or pure HBSS was significantly lower compared
to the Ce6 and Lyso Tracker® signals. The microscopy equipment has been
described elsewhere [18].
3. Results
3.1. Interactions of chlorin e6 with lipid membranes
In the first part of this study, phosphatidylcholine unilamellar
vesicles were used as a simple model of the lipid phase of
biological membranes. To examine the distribution of Ce6
between the outer and inner membrane layers, our study was
Fig. 6. Uptake of Ce6 by HS68 fibroblasts at pH and 7.4 (left) and 6.9 (right) (a)
Ce6 free (5×10−7 M) (b) Ce6 bound to the LDL (1×10−7 M).
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Kuzelova et al. [19]. This model applies to amphiphilic molecules
such as Ce6 bearing polar side chains on one side of the pyrrole
macrocycle. Upon mixing with vesicles, a first phase, character-
ized by a rate constant k1, corresponds to the reversible
incorporation of the photosensitizer into the outer leaflet of the
membrane as shown in Fig. 2. This phase is detected by the
fluorescence changes associated to the transfer of the molecule
from an aqueous to a lipid environment. Then, the molecules
localized in the outer leaflet can flip to the inner leaflet with a rate
constant k2. Consequently, the outer leaflet is available to
incorporate other molecules yielding again fluorescence changes.
Provided that k1Nk2, a two step process is observed and can be
fitted by a biexponential. The experiments with Ce6 were carried
out at pH 7.4 and 6.5 in order to determine the effect of
acidification on the speed of membrane crossing. The pH scale
was chosen to be sufficiently large to insure at least the partial
protonation of the carboxyl groups.
Ce6 and vesicles were mixed in the stopped-flow apparatus,
with the excitation wavelength set at 411 nm. The Ce6
concentration was kept at 5 × 10− 7 M and the DOPC
concentration varied in the range 1–5×10−4 M after mixing.
The DOPC to Ce6 molar ratio was at least 200. Due to this
excess of DOPC, the first phase of the interaction was
considered to obey pseudo-first order conditions. The fluores-
cence signal was fitted by a monoexponential function giving
the pseudo first-order rate constants k1. This constant was found
to linearly depend on the vesicle concentration. The rate
constants for the entrance and exit steps of Ce6 from the outer
layer were derived from this linear fit according to the equation:
k1 ¼ kobson  ½DOPC þ kobsoff ð1Þ
Figs. 3 and 4 show the fluorescence signal of the first phase
(a) and the influence of the vesicle concentration on the rate
constant k1 (inset) leading to kon
obs = (6.88±0.28 )×105 M−1 s−1
and koff
obs =125±12 s−1 at pH 7.4. At pH 6.5, we obtained kon
obs =Fig. 5. Effects of LDL receptor expression on the uptake of LDL bound Ce6 by
HS68 fibroblasts. Cells were incubated for 48 h either in DMEM medium
supplemented with 10% FCS (white) or in DMEM medium supplemented with
2% Ultroser G (grey). Ce6 uptake by the cells was assessed by fluorescence
intensity measurement at 668 nm. The uptake of non-overexpressed cells was
normalized to 100% independently for every experiment (Ce6 free or Ce6-LDL).(5.56±0.12)×105 M−1 s−1 and koff
obs =58±4 s−1. A second
phase was not detectable either on the stopped flow apparatus or
by using the Aminco spectrofluorimeter in kinetics mode for
long records (see below). This means that either the flip-flop
between the two hemileaflets was too slow to be observed or too
fast to be distinguished from the first phase. In order to check
the first hypothesis, conditions that facilitate the flip-flop were
chosen. The temperature was increased up to 37 °C and the
vesicles were made with DMoPC (C14:1), a phospholipid with
shorter chains. As discussed below, both conditions should
favor the flip-flop significantly. Also, a lower pH leading to the
neutralization of the Ce6 carboxylic chains is expected to
accelerate the flip-flop. Upon mixing Ce6 with DMoPC vesicles
at pH 7.4, very slow changes of fluorescence were recorded.
Fig. 3b shows the increase of the fluorescence intensity at
670 nm, corresponding to the fluorescence emitted by Ce6
incorporated in the membrane. The rate constant value
calculated for DMoPC was k2= (2.0±0.3)×10
−3 s−1. The
small fluorescence decrease detected with DOPC vesicles are
more likely due to the Ce6 photobleaching. Fig. 4b shows the
evolution of the fluorescence signal at pH 6.5 using DMoPC
vesicles. The curve was fitted by a monoexponential function
leading to k2= (26.3±0.1)×10
− 3 s−1. The second phase
remained absent with DOPC vesicles.
3.2. Cellular experiments
3.2.1. Cellular uptake
To examine the cellular uptake of Ce6, the HS68 human
fibroblasts were incubated in the same conditions in presence of
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cells were lysed and the concentration of internalized Ce6 was
determined by fluorescence and normalized to the protein
content of the samples. In order to enhance the expression of the
LDL receptors, the cells were incubated in a medium free of
lipoproteins [17,20]. A 48-h preincubation in this medium
resulted in 37% enhancement of cellular uptake of LDL-bound
Ce6, while there was no effect for free Ce6 (Fig. 5). These
results confirm the role of the LDL receptor mediated
internalization pathway.Fig. 7. Fluorescence microscopy study of the Ce6 cellular internalization by HS68 fibr
column (b, e, h, k) represents the LysoTracker® green labeling and the last column (c,
represents the Ce6 localization in the lysosomes. (a, b, c) Cells incubated with [Ce6]=
pH=7.4. (g, h, i) Cells incubated with [Ce6]=1.0 μM, pH=6.9. (j, k, l) Cells incubThe drug uptake was determined at pH 7.4 and 6.9. Fig. 6
represents the amounts of Ce6 incorporated by the cells at pH
7.4. Ce6 is internalized either free or when preloaded to LDL.
However, the concentration of intracellular Ce6 is approximate-
ly 5 times lower, when Ce6 is bound to LDL compared to free
Ce6. The effect of pH is presented in Fig. 6. The acidification
increases the uptake of Ce6 either when it is free in solution or
when it is vectorized by LDL. The ratio of the concentration of
Ce6 incorporated at pH 7.4 to that at 6.9 is approximately 1.3 for
the free and 1.9 for the LDL-bound molecule.oblasts. First column (a, d, g, j) represents the Ce6 fluorescence emission, second
f, i, l) contains superposition of the red and green images. Yellow to orange spots
1.0 μM, pH=7.4. (d, e, f) Cells incubated with [Ce6]=1.0 μM, [LDL]=0.1 μM,
ated with [Ce6]=1.0 μM, [LDL]=0.1 μM, pH=6.9.
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The cellular internalization pathway and the effect of LDL
on the subcellular distribution of Ce6 were investigated by
fluorescence microscopy. Fig. 7 shows that Ce6 is localized in
the plasma membrane and in intracellular vesicles. In order to
identify the nature of these vesicles, the lysosome-specific
probe Lyso Tracker® green was used in co-localization
experiments. Fig. 7 shows the fluorescence images of the
cellular distribution of Ce6 (column 1), that of Lyso-Tracker®
Green (column 2) and the resulting superposed image (column
3) at pH 7.4 and 6.9. In the absence of LDL, Ce6 labels the
plasma membrane and intracellular vesicles (Figs. 7a, g). The
overlap with the Lyso-Tracker Green image shows that only few
vesicles are labeled by both Ce6 and Lyso-Tracker (Figs. 7c, i).
When Ce6 is vectorized by LDL the subcellular localization
is different (Figs. 7d, j). The plasma membrane labeling is no
more visible and Ce6 is mainly located in intracellular vesicles.
The overlap of the red and green images indicates an enhanced
co-localization (Figs. 7f, l). No significant effect of pH on
subcellular distribution is observed.
4. Discussion
4.1. Kinetics of incorporation of Ce6 into liposomes
The extrusion technique is a suitable method producing
vesicles that are sufficiently stable to resist the strong shear
forces in fast mixing experiments. In all preliminary studies
carried out by our group, we find no evidence for diameter
changes or fusion of the extruded vesicles after they were mixed
in the stopped-flow apparatus. Moreover, in the present study
(see below) and a previous one [19] the binding constants
derived from kinetics data and steady state experiments were
identical within experimental errors confirming that the vesicles
were in a similar state. The kinetics experiments described in the
present work complement the steady state data reported
previously [7]. In keeping with the structural similitude between
dicarboxylic porphyrins and Ce6, we assumed that the
incorporation of the chlorin proceeds in two steps. In the first
step, the molecules incorporate into the outer membrane layer
with their macrocycle buried into the lipid core and the charged
lateral chains oriented to the water interface [21]. The second
phase corresponds to a deeper incorporation into the hydro-
phobic core of the membrane and to the redistribution of the
molecules between the two membrane hemileaflets. Depending
on the structure of the photosensitizer and membrane properties,
this phase can be relatively fast (deuteroporphyrin) or might last
for hours (AlPcS2a) [18].
The kinetic study of Ce6 interactions with the DOPC
liposomes has shown that the first phase of the incorporation is
extremely fast. The rate constants for the entrance and exist
steps are kon
obs = (6.88±0.28)×105 M−1 s−1 and koff
obs =125±
12 s−1 at pH 7.4 and kon
obs = (5.56±0.12)×105 M−1 s−1 and
koff
obs =58±4 s−1 at pH=6.5. As reported for deuteroporphyrin
[22], the entrance rate constant, kon
obs, does not significantly
depend on pH in this range. The value for Ce6 is somewhat
lower than that for deuteroporphyrin, 1.69×106 M− 1 s− 1[22], which might be explained by the extra negative charge
of the chlorine molecule. The second phase was not
observable using DOPC liposomes. According to previous
studies from our group, the rate of the transfer between two
membrane leaflets, depends, among other factors, on the pH,
on the temperature and on the hydrophobic barrier formed by
the lipid hydrocarbon chains [21,23]. In order to facilitate the
Ce6 transfer, we used DMoPC vesicles with shorter
hydrocarbon chains. As in the case of DOPC, the melting
temperature of DMoPC is far below zero. In both cases the
bilayer is in a fluid phase. We also increased the temperature
up to 37 °C. Under these conditions, the flip-flop was
relatively slow at pH 7.4 (t1/2 ∼500 s) but it was significantly
accelerated at pH 6.5 (t1/2 ∼40 s).
These results indicate that at pH 7.4, Ce6 populates rapidly
the outer hemileaflet and then crosses the lipid bilayer very
slowly. It can be noted that the rate of flip-flop of membrane
lipids is significantly lower than the one for chlorin e6.
However, phospholipids, chlorin e6 or other carboxylic
photosensitizers such as deuteroporphyrin and AlPcS2a signif-
icantly differ by their polar heads. Chlorin e6 is a good example
illustrating an intermediate behavior between deuteroporphyrin
and AlPcS2a. Due to its three carboxylic groups and relatively
short lateral chains (compared to DP), the PS' macrocyle
localizes near the membrane surface and the flip-flop rate is
considerably reduced compared to deuteroporphyrin. In fact,
the flip-flop was observed at pH 7.4 only for bilayers made of
C14 phospholipids and not observable over hours for more
biological relevant C18 phospholipids. A lower pH favors the
neutralization of the carboxylic groups and the macrocycle can
locate deeper into the membrane and cross the bilayer. It must
be kept in mind that the pK of carboxylic chains of
deuteroporphyrin (and most likely those of chlorin e6) are
significantly shifted to higher values when this molecule in
incorporated within the bilayer as compared to the aqueous
values. In fact, the apparent pKs of deuteroporphyrin in egg
phosphatidylcholine are around 7.3 [24]. On the other hand, the
non-neutralizable sulfonate groups in AlPcS2a impede its
transfer through the membrane.
If we take into account the observedmonoexponential kinetics,
the global binding constant can be defined as KB=kon/koff. The
values calculated, 5.5×103 M−1 for pH 7.4 and 9.6×103 M−1 for
pH 6.5, are in good agreement withKDOPC=(5.9±1.1)×10
3 M−1
for pH 7.4 and KDOPC=(9.1±0.6)×10
3 M−1 for pH 6.5
previously determined by steady state experiments [7]. It should
be noted, that in both static and dynamic experiments, the value of
binding constants are referred to the total lipid concentration
although only the outer membrane leaflet is populated.
4.2. Cellular experiments
Targeting of LDL-bound photosensitizers to neoplastic cells
is one of the important mechanisms of their specific
accumulation in proliferative tissues that over-express LDL-
receptors [10,25–27]. Incorporation of the drugs by specific
LDL-receptor mediated pathway drives them via the endocy-
tosis compartment to lysosomes. Schmidt-Erfurht et al. have
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bound to LDL on fibroblasts and retinoblastoma cells [28].
Covalent binding to LDL significantly increased the uptake of
Ce6 in both cell lines. Saturability and competitive inhibition
studies indicated a receptor-mediated uptake. Binding at 2 °C
also occurred, indicating a degree of non-specific associations.
In our work, Ce6 is bound to LDL only by non-covalent
interactions. Our system reflects the physiological conditions.
Our results take into account the possibility of dynamic
exchanges between all the plasmatic proteins as well as with
the plasmic membrane. This was obviously not feasible with
Ce6 conjugates. The goal of our work was not to target the Ce6
into cells but to understand the natural mechanisms of its
selective retention by cancer cells. Despite evidence for the
important role of the LDL-receptor mediated pathway, the
importance of the LDL route in vivo has been questioned.
Indeed, the tumor localizing ability is not always correlated with
the photosensitizer's affinity for LDL [29]. In fact, great
attention should be paid to the balance between the various
cellular uptake processes, which depends on experimental
conditions as outlined below.
In the present study, we have examined the cellular uptake
and the subcellular localization of Ce6 either free in solution or
preloaded to LDL. The amount of Ce6 associated (not covalently
bound) to LDL is governed by equilibrium and dynamic
constants. The objective was to establish the relative importance
of passive diffusion, bulk endocytosis and LDL-mediated
endocytosis on the uptake of the photosensitizer and on its
subcellular distribution. As outlined in a previous paper, the
partition of Ce6 among plasma proteins and lipid membranes
depends on the ionization state of chlorin carboxylic chains [7].
Hence, a particular attention is given to pH effects.
4.2.1. Chlorin e6 cellular uptake
In agreement with Cunderlikova et al. [30], quantitative
measurements revealed that the overall cellular uptake of Ce6 is
increased upon decreasing pH (see Fig. 6). The enhanced drug
uptake at pH 6.9 can be explained by the increased affinity of
Ce6 toward lipid membrane at lower pH [7]. In the same way,
the higher affinity of LDL for Ce6 at lower pH [7], explains that
the uptake of Ce6 at pH 6.9 is higher than at pH 7.4. The ratio of
intracellular Ce6 concentrations at pH 6.9 to that at 7.4 is
approximately 1.3 for free and 1.9 for LDL-vectorized Ce6.
These values are similar to the values of the ratio between the
DOPC and LDL affinity constants determined at pH 6.5 and
7.4, which are 1.5 and 1.9 for DOPC and LDL respectively [7].
However, when the absolute values expressed as a function of
protein content are considered, the situation appears more
complex. Fig. 6 shows, that in our experimental conditions, the
global cellular uptake of Ce6 is diminished when the drug is
bound to LDL. In fact, two opposite effects should be
considered. Firstly, the plasma membrane and LDL compete
for Ce6 binding. Secondly, cells may take up LDL-bound Ce6
via LDL-mediated endocytosis. The positive or negative effect
of the presence of LDL on Ce6 uptake depends on its relative
affinity for LDL and plasma membrane, on the concentration of
LDL and also on the level of expression of LDL receptors. Theimportance of the last parameter is well exemplified in Fig. 5.
Cells grown in a medium supplemented with Ultroser G,
favoring the expression of LDL receptors, incorporate signif-
icantly more Ce6. It is noteworthy that this medium has no
effect on the uptake of free Ce6.
It must be pointed out that for in vivo conditions Ce6 does not
exist as a freemolecule because it is bound to blood carriers, namely
albumin, HDL and LDL. From a dynamic point of view, the
interactions between Ce6 and LDL or membranes are expected to
be very fast. Experiments in solution have shown that the entrance
and exit from LDL or albumin of amphiphilic photosensitizers take
place withinmilliseconds [19,31]. Interactions withmembranes are
also extremely fast as reported above. No specific mechanism of
cellular uptake of HSA or HDL bound photosensitizers has been
reported so far. Thus, for in vivo conditions, even if the fraction of
Ce6 bound to LDL is low, LDL-mediated endocytosis is likely to
play a crucial role in its internalization pathway. Moreover, the
supply of new LDL to the tumor stroma may lead to further Ce6
uptake. Indeed, as the dynamic of exchange is fast, naive LDL
could extract Ce6 from other carriers.
The distribution of Ce6 among various carriers can be also
modified by pH change. We previously showed [7] that a
decrease of pH from 7.4 to 6.5 increases the affinity of Ce6 for
LDL while its affinity for HSA is decreased. Ultracentrifugation
studies led to the same conclusion [32]. As discussed in a
previous paper, the distribution of Ce6 among its various
carriers is likely to be shifted towards LDL at acidic pH. Indeed,
different studies have shown that the pH of the interstitial fluid
in tumors is lower than that in the normal tissues [8,9]. Both the
overexpression of LDL receptors by neoplastic cells and this pH
effect are likely to contribute to selective retention of
amphiphilic carboxylic photosensitizers by tumors.
4.2.2. Subcellular localization
The subcellular distribution of Ce6 in absence or presence of
LDL fully supports the above analysis. After 15 min incubation
of HS68 fibroblasts with free Ce6 at pH 7.4, the fluorescence
images revealed the presence of chlorin molecules in the plasma
membrane and in intracellular vesicles. No labeling of the
nucleus or cytosolic structures was found. This cellular
distribution reflects the dynamics of the Ce6-membrane
interactions as evidenced by the kinetics experiments on
liposomes. In a first step, due to the lipophilicity of its
macrocycle, Ce6 incorporates into the plasma membrane. It is
worth noting that plasma membrane binding of other amphi-
philic photosensitizers has been evidenced by total internal
reflection fluorescence spectroscopy [33]. In agreement with the
kinetics experiments, the passive diffusion of Ce6 through the
membrane is extremely slow and the Ce6 incorporated in the
plasma membrane is rather internalized in vesicular structures
by absorptive endocytosis. The superposition of the red and
green fluorescence emission of the LysoTracker® revealed only
little Ce6 localization in the lysosomes (see Figs. 7a, b, c).
When the cells were incubated with Ce6-preloaded LDL, the
chlorin was found to be localized mainly in intracellular vesicles
(see Figs. 7d, e, f). The plasma membrane was not labeled.
These results indicate that the balance between binding of Ce6
2755H. Mojzisova et al. / Biochimica et Biophysica Acta 1768 (2007) 2748–2756to membranes and LDL is shifted towards LDL favoring the
drug uptake via the apo B/E receptor specific endocytosis. As a
matter of fact, the overlap between Ce6 and LysoTracker®
fluorescence shows that a main part of the photosensitizer is
localized in lysosomes. Similar results were obtained with
aluminum disulfonated phthatocyanine [18], a molecule also
known for its inability to cross lipid bilayers [34].
As shown in Figs. 7g–l, pH decrease did not significantly
modify the sub-cellular localization ofCe6 either free of associated
to LDL. Little evidence for Ce6 internalization via passive
diffusionwas observed in agreementwith the results onmembrane
models showing that a lipid bilayer with a biologically relevant
thickness constitutes an efficient barrier even at the lower pH.
5. Conclusion
The present results provide new data to better understand the
relationship between the structural parameters of photosensiti-
zers and the dynamics of their interactions with membranes and
lipoproteins. Together with results on porphyrins and phthalo-
cyanines, these data can be further extrapolated to predict the
impact of these interactions on the internalization pathway and
subcellular distribution of these drugs.
The subcellular distribution of photosensitizers is a major
determinant of their biological efficacy. Localization in the
plasma membrane, mitochondria, endoplasmic reticulum and
Golgi apparatus ensure the more efficient photoinduced cell
death and the destruction of pathologic tissue in the context of
photodynamic therapy [35,36]. On the other hand, the
endosome/lysosomal localization of Ce6 can be further
exploited in a new technology— photochemical internalization
(PCI) [37]. In this approach the photochemical reactions break
up the endosome/lysosome membrane and facilitate the
liberation of drugs internalized by endocytosis. This technology
has found applications in vitro as well as in vivo. The present
results show that attention should be paid to the role of LDL as
determinants of the subcellular localization, especially in vivo.
Although, other mechanisms may come into play and/or other
tumor compartments may be also involved, these data support
the LDL route as an important selectivity factor.
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